Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 542
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06346041 | Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors | ||
| NCT06405256 | Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Large Brain Metastases | ||
| NCT06750861 | QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC | ||
| NCT03058094 | A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI | ||
| NCT05541445 | Pembrolizumab Plus CRT Followed by Surgery in Upper ESCC | ||
| NCT06553365 | Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors | ||
| NCT03448549 | SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients | ||
| NCT04012645 | Perfusion Outcomes With Near Infrared-Indocyanine Green Imaging System in Laparoscopic Total Mesorectal Excision for Mid- or Low-rectal CanceR | ||
| NCT06959732 | Zanubrutinib Combined With G-CVP in Previously Untreated FL | ||
| NCT07586657 | Precision Radiotherapy for Refractory Brain Metastases: A Multicenter Study | ||
| NCT06921044 | A Study of R-mini-MCOP in the Treatment of Elderly, Previously Untreated DLBCL | ||
| NCT06889402 | Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy | ||
| NCT06150365 | Personalized KSX01-TCRT in Patients With Advanced Solid Tumors | ||
| NCT04857164 | Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China | ||
| NCT07186621 | Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC | ||
| NCT07612098 | Preoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma | ||
| NCT07324798 | Adaptive Radiotherapy for Genitourinary Cancers | ||
| NCT05431504 | The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral Crisis | ||
| NCT05865132 | Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction | ||
| NCT03381430 | Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFR | ||
| NCT06198907 | Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC) | ||
| NCT05352646 | NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection | ||
| NCT02503150 | Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer | ||
| NCT01391260 | Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC) | ||
| NCT06411457 | SHR-A1811 in Combination With Adebrelimab for the Treatment of HER2 Low-expressing Metastatic Breast Cancer | ||
| NCT05028439 | RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma | ||
| NCT07034742 | Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer | ||
| NCT06082557 | A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients | ||
| NCT07405346 | A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy | ||
| NCT07038629 | Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC | ||
| NCT06156761 | Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer | ||
| NCT04213937 | Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung Cancer | ||
| NCT03014102 | Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation | ||
| NCT05888402 | Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC | ||
| NCT03189277 | A Hospital Based Survey on Lung Cancer Related-pain in Northern China | ||
| NCT07307053 | Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2) | ||
| NCT05443672 | Multi-center Study of Deep Learning AI in Breast Mass | ||
| NCT04207918 | A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer | ||
| NCT06820320 | Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy | ||
| NCT06752148 | Quantitative Neurofeedback Techniques for Treating Perioperative Cognitive Disorders in Elderly Patients | ||
| NCT07186855 | Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC | ||
| NCT05318443 | A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer | ||
| NCT04840355 | Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Sintilimab in Clinical Practice Among Chinese Patients | ||
| NCT06430658 | Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer | ||
| NCT02646735 | Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients | ||
| NCT06241079 | Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma | ||
| NCT01733589 | Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC | ||
| NCT06417892 | Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma | ||
| NCT06543836 | ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer | ||
| NCT06421376 | Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer |
